Fig. 5From: Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trialStudy protocol. CS caesarean section, ETP-EPP thrombin and plasmin generation potential in a wellBack to article page